These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12176304)

  • 1. Slow-release melarsoprol microparticles.
    Gibaud S; Gaia A; Astier A
    Int J Pharm; 2002 Aug; 243(1-2):161-6. PubMed ID: 12176304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.
    Gibaud S; Bonneville A; Astier A
    Int J Pharm; 2002 Aug; 242(1-2):197-201. PubMed ID: 12176246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
    Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
    J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.
    Gibaud S; Jabir Al Awwadi N; Ducki C; Astier A
    Int J Pharm; 2004 Jan; 269(2):491-508. PubMed ID: 14706260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.
    Jaraswekin S; Prakongpan S; Bodmeier R
    J Microencapsul; 2007 Mar; 24(2):117-28. PubMed ID: 17454423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of sustained release microparticles with improved initial release property.
    Jung GY; Na YE; Park MS; Park CS; Myung PK
    Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
    Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
    Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles.
    Onishi H; Machida Y; Koyama K
    Drug Dev Ind Pharm; 2007 Jun; 33(6):641-7. PubMed ID: 17613028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physico-chemical properties of the trypanocidal drug melarsoprol.
    Keiser J; Burri C
    Acta Trop; 2000 Jan; 74(1):101-4. PubMed ID: 10643914
    [No Abstract]   [Full Text] [Related]  

  • 13. Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model.
    Lionzo MI; Ré MI; Guterres SS; Pohlmann AR
    J Microencapsul; 2007 Mar; 24(2):175-86. PubMed ID: 17454428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro characteristics for insulin-loaded PLA microparticles prepared by w/o/w solvent evaporation method with electrolytes in the continuous phase.
    Yeh MK; Chen JL; Chiang CH
    J Microencapsul; 2004 Nov; 21(7):719-28. PubMed ID: 15799222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
    Karataş A; Sonakin O; Kiliçarslan M; Baykara T
    J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of antimicrobial ceftiofur drugs.
    Bodmeier R; Chen H; Davidson RG; Hardee GE
    Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems.
    Ahmed AR; Dashevsky A; Bodmeier R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):765-9. PubMed ID: 18692569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
    Haddadi A; Aboofazeli R; Erfan M; Farboud ES
    J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.